Intrinsic Edge Capital Management’s Exact Sciences EXAS Stock Holding History

Intrinsic Edge Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200,000	Closed	-$15.6M	–	196
2021 Q4	$15.6M	Buy	+200,000	New	+$17.7M	0.99%	30
2019 Q3	–	Sell	-150,000	Closed	-$17.7M	–	160
2019 Q2	$17.7M	Buy	+150,000	New	+$15.1M	2.11%	11
2018 Q4	–	Sell	-473	Closed	-$932K	–	137
2018 Q3	$932K	Buy	+473	New	+$30.8K	0.15%	120
2017 Q2	–	Sell	-900	Closed	-$760K	–	122
2017 Q1	$760K	Buy	+900	New	+$17.8K	0.23%	100

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Intrinsic Edge Capital Management's EXAS Position: Q4 2023 in Review

Intrinsic Edge Capital Management sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 181,984 shares — an estimated $12.4M sold.

Intrinsic Edge Capital Management first reported a position in EXAS in Q4 2016 and held it in 23 quarters. The position peaked at $23.1M in Q2 2019. 648 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

Intrinsic Edge Capital Management reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
Intrinsic Edge Capital Management sold 181,984 Exact Sciences shares in Q4 2023, an estimated $12.4M.
Intrinsic Edge Capital Management first reported a position in Exact Sciences in Q4 2016 and held it in 23 quarters.
Intrinsic Edge Capital Management's Exact Sciences position peaked at $23.1M in Q2 2019.
648 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Intrinsic Edge Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.